
CRISPR therapeutics can damage the human genome, TAU researchers warn
A new study from Tel Aviv University (TAU) identifies risks in the use of CRISPR therapeutics, the innovative, Nobel-prize-winning method that involves cleaving and editing DNA, already employed for the treatment of conditions like cancer, liver and intestinal diseases, and genetic syndromes. The researchers detected a loss of genetic material in up to 10% of… Read More